Nikon

Medmain Inc. is a company specializing in the development of software solutions for pathology diagnosis, founded in 2018 and headquartered in Fukuoka City, Japan, with additional offices in Tokyo and the United States. The company offers a range of products, including PidPort, which utilizes machine learning and artificial intelligence for rapid pathology diagnosis, and Medteria, an online platform providing educational resources for medical students. Medmain's technology enhances operational efficiency for medical institutions by facilitating accurate pathological image analysis and supporting telepathology consultations. Their innovative solutions also assist pharmaceutical companies and contract research organizations in drug discovery efforts, promoting collaboration through online diagnostic platforms and conferences.

RED Digital Cinema is an American company based in Los Angeles, California, specializing in the manufacturing of professional digital cinema cameras and accessories. Founded in 2005, the company is known for its commitment to providing cinema-grade image quality and impressive dynamic range in its products. RED offers a range of HD video cameras, digital still and motion cameras, lenses, and various accessories, including modules, displays, media products, and power solutions. Its cameras feature advanced capabilities such as wireless control and interchangeable optical filters, catering to the needs of cinematographers in the cinema, television, and photography industries. RED sells its products online and through retail outlets, serving a global customer base across North America, Europe, and Asia.

Ai Build Limited is a London-based company specializing in artificial intelligence and robotic technologies for large-scale additive manufacturing. Established in 2015, the firm provides a comprehensive solution that includes cloud-based software, robotic extruders, and specialized enclosures to facilitate autonomous 3D printing of large products. Their technology allows factories to produce complex parts and structures using recycled materials, enhancing efficiency while minimizing waste and costs. Ai Build supports various industries, including aerospace, automotive, marine, construction, and energy, by offering continuous infrastructure and technical support throughout the subscription period. The company's mission is to transform manufacturing into a more sustainable and accessible process, empowering the factories of the future with innovative solutions for on-demand production.

Hybrid Manufacturing Technologies specializes in the production of industrial 3D printers and CNC machines that integrate industrial 3D printing with laser cladding, utilizing patented tool-changeable laser cladding heads. The company is recognized as a leader in hybrid manufacturing, offering a range of services that include metal additive manufacturing, coatings, repairs, tooling, and part enhancement. By combining these complementary technologies within a single machine, Hybrid Manufacturing Technologies provides enhanced technical capabilities such as in-process finishing and inspection, which are not achievable through either technology alone. The company's commitment to precision machining and innovative part manufacture positions it as a key player in the manufacturing sector, delivering unmatched flexibility through its proprietary laser metal deposition systems.

Asilla, Inc. is a technology company specializing in artificial intelligence-based image and video analysis. Established in 2015 and headquartered in Tokyo, Japan, with an additional office in Hanoi, Vietnam, Asilla develops a range of applications that leverage AI for various purposes. Its offerings include an AI-OCR (Optical Character Recognition) system that facilitates the extraction of text from images and videos, enabling the digitization of visual content into actionable data. The company also provides services for recognizing vehicles by make and model, as well as a censorship tool that identifies inappropriate content, including copyright violations and obscene material. Furthermore, Asilla's technology is designed to detect human behavioral anomalies, supporting applications in security, facility management, mobility, smart cities, and smart agriculture, thereby enhancing safety and crime prevention measures across multiple sectors.

SLM Solutions Group AG specializes in metal-based additive manufacturing technology, providing innovative solutions both in Germany and internationally. The company operates through two main segments: Machine Business and After Sales Business. The Machine Business segment focuses on the development, production, marketing, and sale of machines and peripheral equipment specifically for selective laser melting. Meanwhile, the After Sales Business segment offers services related to machine maintenance, as well as the sale of replacement parts, accessories, and consumables. Additionally, SLM Solutions provides additive quality software, catering to various industries including aerospace, mechanical engineering, tool construction, automotive, medical technology, and energy. The company is headquartered in Lübeck, Germany.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

XenomatiX specializes in developing automotive vision systems for advanced driver assistance systems (ADAS) and autonomous driving applications. Their solutions employ complementary metal oxide semiconductor-based detectors, multi-beam laser projectors, and light detection and ranging technology to provide real-time 3D digitization of a vehicle's surroundings. Additionally, their solid-state LiDAR solutions cater to industries such as road construction, surveying, industrial, mining, agriculture, off-road vehicles, and railways.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

XTIA Co., Ltd., established in 2002 and headquartered in Tokyo, Japan, specializes in the development, manufacture, and sale of high-precision measurement instruments and 3D scanners. The company's core technology, the patented optical frequency comb laser (Optocomb), enables non-contact, micrometer-precise detection of objects up to 78 meters away. Xtia's products cater to diverse industries, including automotive, aerospace, and heavy industry, aiding in quality improvement, automated inspection, and digital and visual inspection applications. The company collaborates with major Japanese and international corporations to integrate its unique technology into their operations, enhancing automation, smart factory initiatives, and telecommunication advancements.

LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

wrnch is a computer vision and deep learning software engineering company based in Montréal, Canada, known for its innovative contributions to artificial intelligence, special effects, and game technology. Founded by Dr. Paul Kruszewski, a seasoned AI entrepreneur, wrnch has developed a real-time software platform that enables cameras to understand and interpret human motion and activity in video. Utilizing a deep learning runtime engine, the company's technology performs human pose estimation by analyzing standard 2D video and generating 3D motion data in real time. This capability allows wrnch to process multiple 2D camera feeds while tracking various body parts, making its solutions applicable across diverse industries such as robotics, retail, and entertainment. The company has achieved profitability and has garnered support from experienced investors.

QD Laser, Inc. is a manufacturer of quantum dot semiconductor lasers and wafers, utilizing GaAs substrates for various applications in communications and industry. Established in 2006 and based in Kawasaki, Japan, the company specializes in creating a diverse range of high-performance laser products, including picosecond short-pulse DFB lasers for precision processing, current injection-type lasers in green, yellow-green, and orange for biological sciences, and quantum dot laser arrays for silicon optical circuits. Additionally, QD Laser produces broadband gain chips for ophthalmic testing and retinal imaging laser eyewear. Their technology serves multiple sectors, including telecommunications, manufacturing, medicine, and consumer products, allowing for advancements in fields like silicon photonics, sensing, and precision machining.

Velodyne Lidar is a leading global provider of lidar technology, recognized as the first public pure-play lidar company. Under the leadership of CEO Anand Gopalan, the company focuses on enhancing safety, efficiency, and sustainability in mobility and smart city applications through its innovative lidar solutions. Velodyne offers a comprehensive range of hardware and software products designed to meet the diverse needs of various industries, including autonomous vehicles, advanced driver-assistance systems, robotics, and security. Their technology plays a crucial role in advancing autonomous systems, enabling applications such as autonomous tractors for logistics, and robots for hazardous tasks like rescue missions and construction support. Velodyne's mission is to foster universally accessible mobility solutions that contribute to safer and smarter communities.

Berkeley Lights, Inc. is a digital cell biology company based in Emeryville, California, established in 2011. The company specializes in the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights offers an integrated platform that includes proprietary consumables such as OptoSelect chips and reagent kits, along with automation systems and application software. Utilizing innovative micro-droplet technology, the company transforms biological processes, enabling researchers to study cell interactions more effectively. This platform supports various applications, including biotherapeutic discovery and development, cellular therapy manufacturing, and synthetic biology, addressing the growing demands in these fields.

Unirobot Corporation, founded in 2014 and based in Tokyo, Japan, specializes in the development, manufacture, and sale of next-generation social robots. The company focuses on creating robotic systems that enhance social interaction and communication, particularly for elderly individuals and children. These robots utilize artificial intelligence to recognize and remember family members' faces, provide emotional support, and assist with household tasks. UniRobot's innovations are aimed at improving the quality of life by offering companionship and facilitating independent living for users, thereby addressing the growing demand for domestic assistance and social engagement.

Berkeley Lights, Inc. is a digital cell biology company based in Emeryville, California, established in 2011. The company specializes in the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights offers an integrated platform that includes proprietary consumables such as OptoSelect chips and reagent kits, along with automation systems and application software. Utilizing innovative micro-droplet technology, the company transforms biological processes, enabling researchers to study cell interactions more effectively. This platform supports various applications, including biotherapeutic discovery and development, cellular therapy manufacturing, and synthetic biology, addressing the growing demands in these fields.

Gatari Corporation is a Japan-based company that focuses on developing social virtual reality (VR) applications and augmented reality (AR) communication technologies. The company specializes in creating immersive experiences that blend real and digital spaces, allowing users to engage with their environment through interactive sound and visuals. Among its notable products are Auris, a futuristic audio guide, and Vismuth, a camera app that transforms reality into a narrative experience. By leveraging advanced game engines and technology, Gatari aims to enhance communication and interaction in virtual environments, providing users with unique audio-visual experiences.

Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Tribogenics is a technology development company based in Los Angeles, California, focused on creating low-cost, portable X-ray solutions for various industries, including mining, industrial, military, and medical imaging. Utilizing triboluminescence technology originally developed at UCLA, the company has designed miniature X-ray devices that leverage a process akin to static electricity to generate X-rays. This innovative approach allows for convenient and accessible X-ray functions, enabling customers to conduct materials analysis and imaging in diverse settings without the constraints of traditional, larger X-ray systems.

Optos plc is a manufacturer of advanced retinal imaging devices aimed at enhancing patient care in the eyecare sector. The company specializes in ultra-widefield, high-resolution digital imaging, producing optomaps that capture approximately 82% of the retina in a single image, a capability unmatched by other devices. Optos offers a diverse range of imaging products tailored for various customer segments and patient needs. The P200 and 200Dx devices are designed for wellness screening by optometrists and ophthalmologists in primary care, while the P200C devices cater to the more demanding clinical imaging requirements in secondary care and those managing advanced ocular diseases. Additionally, the P200MA and 200Tx devices support ophthalmologists and retinal specialists in delivering medical care. By providing these innovative tools, Optos enables eyecare professionals to discover, diagnose, document, and treat ocular pathologies that may otherwise go unnoticed with traditional examination techniques.

Healios is a biotechnology company focused on developing regenerative and cellular medicines. It aims to commercialize the world’s first pharmaceutical transplantation of retinal pigment epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSCs) for the treatment of age-related macular degeneration (AMD). In collaboration with RIKEN, a prominent research institute in Japan, Healios seeks to promote retinal function regeneration and enhance visual function in individuals suffering from retinal degenerative diseases. The company's efforts underscore its commitment to leveraging innovative hiPSC technology to make significant advancements in the field of regenerative medicine.